{
    "nct_id": "NCT06675357",
    "official_title": "Novel FAP-targeted Approach to Metastatic Prostate Cancer",
    "inclusion_criteria": "* Age 18 years or older\n* Able and willing to provide informed consent\n* Known diagnosis of prostate cancer with established or suspected non-osseous, non-nodal metastases\n* Scheduled for or recently performed (within 4 weeks) standard-of-care PSMA PET\n* Optional: Scheduled for SOC biopsy of an established or suspected non-osseous, non-nodal metastases.\n* Willing and able to undergo PET/MRI as part of this research\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Unable or unwilling to provide informed consent\n* Contraindication(s) to or inability to undergo PET/MRI\n* Participants for whom PET/MRI will delay timely delivery of treatment\n* Participants requiring intravenous (IV) conscious sedation for imaging care; those requiring mild, oral anxiolytics for the clinical MRI will be allowed to participate as long as the following criteria are met:\n* Have their own prescription for the medication\n* The informed consent process is conducted prior to the self-administration of this medication\n* Come to the research visit with a driver",
    "miscellaneous_criteria": ""
}